BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28774201)

  • 1. Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study.
    Ramadan WH; Sarkis AT
    Chron Respir Dis; 2017 Aug; 14(3):309-320. PubMed ID: 28774201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Persistence to treatment by type of inhaler device in patients with asthma and chronic obstructive pulmonary disease].
    Sicras A; Ferrer V; Collar JM; Navarro R; Sáez M
    Semergen; 2017; 43(5):375-386. PubMed ID: 27425817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
    Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
    BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of real-life data on the use of inhaler devices, including satisfaction and adherence to treatment, by community pharmacists in partnership with pulmonary disease specialists.
    Gemicioglu B; Gungordu N; Can G; Alp Yıldırım FI; Uydeş Doğan BS
    J Asthma; 2023 Jul; 60(7):1326-1335. PubMed ID: 36332164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical problems with aerosol therapy in COPD.
    Rau JL
    Respir Care; 2006 Feb; 51(2):158-72. PubMed ID: 16441960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of errors in inhaler technique among COPD versus asthma patients.
    Ocakli B; Ozmen I; Tunçay EA; Gungor S; Altinoz H; Adiguzel N; Sak ZA; Gungor G; Karakurt Z; Arbak P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2941-2947. PubMed ID: 30288037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.
    Levy ML; Carroll W; Izquierdo Alonso JL; Keller C; Lavorini F; Lehtimäki L
    Adv Ther; 2019 Oct; 36(10):2547-2557. PubMed ID: 31478131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of inhaler technique, adherence to therapy and their effect on disease control among children with asthma using metered dose or dry powder inhalers.
    Capanoglu M; Dibek Misirlioglu E; Toyran M; Civelek E; Kocabas CN
    J Asthma; 2015 Oct; 52(8):838-45. PubMed ID: 26037396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
    van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
    NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
    Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
    Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.
    Jones R; Martin J; Thomas V; Skinner D; Marshall J; Stagno d'Alcontres M; Price D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2445-2454. PubMed ID: 28860739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of patients' preferences and sensory perceptions of three forms of inhalers among Thai asthma and COPD patients.
    Bunnag C; Fuangtong R; Pothirat C; Punyaratabandhu P
    Asian Pac J Allergy Immunol; 2007; 25(2-3):99-109. PubMed ID: 18035796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mishandling of pMDI and DPI inhalers in asthma and COPD - Repetitive and non-repetitive errors.
    Luczak-Wozniak K; Dabrowska M; Domagala I; Miszczuk M; Lubanski W; Leszczynski A; Krenke R
    Pulm Pharmacol Ther; 2018 Aug; 51():65-72. PubMed ID: 29964174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
    Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
    BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma.
    Hua JL; Ye XF; Du CL; Xie N; Zhang JQ; Li M; Zhang J
    BMC Pulm Med; 2021 Sep; 21(1):302. PubMed ID: 34560863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ELLIPTA Dry Powder Versus Metered-Dose Inhalers in an Optimized Clinical Trial Setting.
    Kerwin EM; Preece A; Brintziki D; Collison KA; Sharma R
    J Allergy Clin Immunol Pract; 2019; 7(6):1843-1849. PubMed ID: 30836228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β
    Wittbrodt ET; Millette LA; Evans KA; Bonafede M; Tkacz J; Ferguson GT
    Int J Chron Obstruct Pulmon Dis; 2019; 14():101-114. PubMed ID: 30613140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.